BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18990581)

  • 1. Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron.
    Thisgaard H; Jensen M
    Appl Radiat Isot; 2009 Jan; 67(1):34-8. PubMed ID: 18990581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 119Sb--a potent Auger emitter for targeted radionuclide therapy.
    Thisgaard H; Jensen M
    Med Phys; 2008 Sep; 35(9):3839-46. PubMed ID: 18841834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium to large scale radioisotope production for targeted radiotherapy using a small PET cyclotron.
    Thisgaard H; Jensen M; Elema DR
    Appl Radiat Isot; 2011 Jan; 69(1):1-7. PubMed ID: 20724171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
    Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
    Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of a cyclotron in the production of positron emitting radionuclides].
    Martí-Climent J; Peñuelas I; Calvo R; Giménez M; Gámez C; Richter J
    Rev Esp Med Nucl; 1999 Aug; 18(4):261-7. PubMed ID: 10481107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-standard radionuclide production for PET in Japan.
    Fujibayashi Y; Suzuki K; Fukumura T; Mori T; Kasamatsu S
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):140-4. PubMed ID: 18043540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radionuclide production and yields at Washington University School of Medicine.
    Tang L
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):121-33. PubMed ID: 18043542
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Fonslet J; Lee BQ; Tran TA; Siragusa M; Jensen M; Kibédi T; Stuchbery AE; Severin GW
    Phys Med Biol; 2017 Dec; 63(1):015026. PubMed ID: 29286003
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimization of production yields, radionuclidic purity and hotcell shielding of SPECT and PET radionuclides produced by proton irradiation in variable energy 30 MeV cyclotrons--Part 67Ga.
    Adam-Rebeles R; Van den Winkel P; De Vis L
    Appl Radiat Isot; 2007 Sep; 65(9):995-1013. PubMed ID: 17624794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and dosimetric aspects of the potent Auger emitter 58mCo for targeted radionuclide therapy of small tumors.
    Thisgaard H; Elema DR; Jensen M
    Med Phys; 2011 Aug; 38(8):4535-41. PubMed ID: 21928624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
    Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
    J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-energy electron emitters for targeted radiotherapy of small tumours.
    Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G
    Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
    Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V
    Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-particle induced reactions on natSb and 121Sb with particular reference to the production of the medically interesting radionuclide 124I.
    Hassan KF; Qaim SM; Saleh ZA; Coenen HH
    Appl Radiat Isot; 2006 Jan; 64(1):101-9. PubMed ID: 16125943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple Cu-64 production and its application of Cu-64 ATSM.
    Kim JY; Park H; Lee JC; Kim KM; Lee KC; Ha HJ; Choi TH; An GI; Cheon GJ
    Appl Radiat Isot; 2009; 67(7-8):1190-4. PubMed ID: 19299153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with
    Kostelnik TI; Olson AP; Grundmane A; Ellison PA; Mynerich J; Chen S; Marinova A; Randhawa P; Karaivanov D; Aluicio-Sarduy E; Barnhart TE; Orvig C; Ramogida CF; Hoehr C; Filosofov D; Engle JW; Radchenko V
    Nucl Med Biol; 2023; 122-123():108352. PubMed ID: 37390607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy.
    Nelson BJB; Andersson JD; Wuest F
    Nucl Med Biol; 2022; 110-111():59-66. PubMed ID: 35487834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental study and nuclear model calculations on the 192Os(p,n)192Ir reaction: Comparison of reactor and cyclotron production of the therapeutic radionuclide 192Ir.
    Hilgers K; Sudár S; Qaim SM
    Appl Radiat Isot; 2005 Jul; 63(1):93-8. PubMed ID: 15866453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy.
    Bakht MK; Sadeghi M
    Ann Nucl Med; 2011 Oct; 25(8):529-35. PubMed ID: 21720780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New method for production of
    Moiseeva AN; Aliev RA; Furkina EB; Novikov VI; Unezhev VN
    Nucl Med Biol; 2022; 106-107():52-61. PubMed ID: 35032789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.